CAS NO 1190389-15-1 Vibegron Pharmaceutical Intermediates
Product detail
Vibegron is a novel pharmaceutical compound that acts as a selective beta-3 adrenergic receptor agonist. It is primarily used to treat overactive bladder (OAB) syndrome, which is characterized by urinary urgency, urinary frequency, and urinary incontinence. By stimulating beta-3 adrenergic receptors in the bladder, Vibegron promotes detrusor muscle relaxation, thereby increasing bladder capacity and reducing urinary urgency. This innovative mechanism of action makes Vibegron a valuable addition to existing treatment options for the treatment of OAB.
product detail
|
CAS No. |
40856-44-8 |
|
EINECS |
609-874-3 |
|
Formula |
C9H11NO2 |
|
Molecular Weight |
165.19 |
|
Appearance |
White to Off-White solid |
|
Purity |
≥98% |
|
Type |
Pharmaceutical Intermediates |
In summary, Vibegron is a high-quality pharmaceutical compound with great potential in the treatment of overactive bladder. With our commitment to quality, expertise and customer satisfaction, we are a trusted partner for all your pharmaceutical needs. Contact us today to learn more about our products and how we can support your pharmaceutical development projects. Our commitment to innovation and excellence ensures that you receive the best possible products tailored to your specific requirements.



